Molly Klein

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 225 citations · Full text

Medicine, Oncology, Breast Oncology +15

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis

Molly Klein, David J. Dabbs, Yongli Shuai et al. · Modern Pathology · 2013 · 194 citations · Full text

Medicine, Oncology, Pathology +17

High False-Negative Rate of <i>HER2</i> Quantitative Reverse Transcription Polymerase Chain Reaction of the Onco<i>type</i> DX Test: An Independent Quality Assurance Study

David J. Dabbs, Molly Klein, Syed K. Mohsin et al. · Journal of Clinical Oncology · 2011 · 155 citations · Full text

Medicine, Molecular Biology, Oncology +17

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells

Boris Winterhoff, Makayla Maile, Amit Mitra et al. · Gynecologic Oncology · 2017 · 137 citations

Medicine, Cell Biology, Oncology +17

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer

W. Fraser Symmans, Christina Yau, Yunn-Yi Chen et al. · JAMA Oncology · 2021 · 106 citations · Full text

Medicine, Oncology, Breast Oncology +16